Does Butyrate Reduce Inflammation? What the Research Shows

Most people have heard that gut health and inflammation are connected, but the connection is often described in vague terms. Butyrate is where that connection becomes specific and biochemically precise. It is a molecule that gut bacteria make for you, provided you feed them the right ingredients, and it has effects on inflammation that reach well beyond the digestive tract. The research on butyrate has accelerated over the past decade, moving from animal studies and cell culture work into human randomized trials, and the picture that has emerged is both compelling and usefully nuanced.

What Butyrate Is and Where It Comes From

Butyrate belongs to a class of molecules called short-chain fatty acids (SCFAs), which are the metabolic end products of bacterial fermentation in the large intestine. The three main SCFAs are acetate, propionate, and butyrate. Of the three, butyrate is the one that receives the most attention in inflammation research because it is the preferred fuel of colonocytes and has the most direct anti-inflammatory signaling activity.

Butyrate production depends almost entirely on the availability of fermentable dietary fiber. Fermentable fibers, found in foods such as oats, legumes, cooked and cooled potatoes, garlic, onions, leeks, asparagus, and unripe bananas, pass through the small intestine undigested and reach the colon intact, where bacteria ferment them into SCFAs. Without adequate fiber, the butyrate-producing bacterial species decline, and production drops accordingly. This is one of the core reasons that dietary fiber consistently shows anti-inflammatory effects in human studies: a meaningful portion of those effects runs through butyrate.

Small amounts of butyrate also arrive from food directly, particularly from butter and other dairy fats, but dietary butyrate contributes far less than what a well-fed microbiome produces. The gut bacteria are the primary manufacturing plant. This is also why antibiotic use, highly processed diets, and conditions that disrupt microbial diversity tend to reduce butyrate levels. There is no convenient way to eat enough butter to compensate for a microbiome that is not producing butyrate on its own.

How Butyrate Suppresses Inflammation at the Molecular Level

The anti-inflammatory effects of butyrate operate through several overlapping mechanisms, the most important of which is inhibition of NF-kB signaling. NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) is the master transcription factor that switches on genes for pro-inflammatory cytokines like interleukin-1 beta (IL-1B), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). Butyrate inhibits the enzymes (histone deacetylases, or HDACs) that NF-kB depends on to activate inflammatory gene transcription. By blocking HDAC activity, butyrate effectively turns down the volume on the inflammatory gene program inside immune and epithelial cells.

A second major mechanism involves the NLRP3 inflammasome, the multiprotein complex that produces the most potent inflammatory cytokines in the body. A 2020 randomized controlled trial published in the journal Cytokine found that oral sodium butyrate supplementation in people with type 2 diabetes significantly downregulated gene expression of TLR2/4, NF-kB1, Caspase-1, NLRP3, IL-1B, and IL-18 compared with placebo (Roshanravan et al., 2020). This is a direct demonstration that butyrate dampens the inflammasome pathway in a human clinical setting, not just in cell cultures or animal models.

Butyrate also reinforces the intestinal barrier, which matters for systemic inflammation because a leaky gut allows bacterial fragments called lipopolysaccharide (LPS) to cross into the bloodstream and trigger body-wide inflammatory responses. Butyrate promotes the expression of tight-junction proteins that hold the cells of the gut lining together. When these proteins are adequate, fewer bacterial products pass through the gut wall, less LPS enters circulation, and the systemic inflammatory burden is lower. This gut-barrier effect is why butyrate has attracted research attention not just for gut conditions like inflammatory bowel disease, but also for conditions associated with low-grade systemic inflammation such as metabolic syndrome and type 2 diabetes.

What Human Clinical Trials Show

The clinical evidence for butyrate reducing inflammation in humans has strengthened considerably in recent years. A randomized placebo-controlled trial published in 2024 in the journal Lipids in Health and Disease enrolled 36 patients with active ulcerative colitis and randomized them to receive either sodium butyrate (600 mg per day) or placebo for 12 weeks. The butyrate group showed a statistically significant reduction in both high-sensitivity CRP (hs-CRP) and fecal calprotectin, a marker of intestinal inflammation, compared with the placebo group, alongside improvements in sleep quality and quality of life (Firoozi et al., 2024). This trial is notable because it used a validated CRP measurement in a head-to-head randomized design, the gold standard for establishing causality.

Converging evidence comes from a 2025 intervention study published in the Journal of Translational Medicine that tracked inflammatory biomarkers across three dietary supplement interventions. The study found that increases in serum butyrate following a synbiotic intervention (fermented kefir plus prebiotic fiber) correlated directly with reductions in IL-6, one of the main cytokines driving the acute-phase response that produces CRP (Vijay et al., 2025). The synbiotic produced the broadest and strongest anti-inflammatory effects of the three interventions tested, and the butyrate-IL-6 correlation helps explain why.

A 2025 meta-analysis published in Frontiers in Cellular and Infection Microbiology pooled 46 randomized controlled trials comprising 3,580 diabetic patients and found that probiotic and synbiotic interventions produced significant reductions in CRP (standardized mean difference of -0.54), IL-6 (SMD -0.41), and TNF-alpha (SMD -0.48). Meta-regression analysis identified butyrate levels as a strong predictor of anti-inflammatory efficacy across the trials, with higher butyrate increases correlating with greater CRP reductions (Xie et al., 2025). This kind of dose-response relationship within a meta-regression strengthens the case for butyrate as an active mediator rather than a coincidental marker.

The evidence is clearest in people with active gut inflammation or metabolic disease, populations where the inflammatory system is already engaged and has more room to respond. In healthy adults with low baseline CRP, effects on systemic inflammation are likely smaller and harder to detect in short trials. This mirrors patterns seen with other anti-inflammatory nutrients and supplements: the benefit shows most clearly when there is genuine dysfunction to correct.

Butyrate and the Gut Microbiome Connection

Understanding butyrate requires thinking about it as the product of an ecosystem, not a single nutrient. A handful of bacterial species do most of the butyrate production in the human colon: Faecalibacterium prausnitzii is one of the most studied, and its abundance in the gut microbiome is consistently lower in people with inflammatory bowel disease, metabolic syndrome, and other conditions characterized by elevated inflammation. Roseburia intestinalis and members of the Clostridiales order are also key producers.

These bacteria need fermentable fiber as their raw material, and they need it consistently. Inulin, found in chicory root, garlic, and leeks, is particularly well fermented into butyrate. Resistant starch, found in cooked and cooled potatoes, green bananas, and legumes, is another potent substrate. Pectin from apples and berries, and beta-glucan from oats and barley, also support SCFA production though butyrate generation varies by individual microbiome composition. This is a crucial point: the fiber feeds the bacteria, the bacteria make the butyrate, and the butyrate does the anti-inflammatory work. Dietary patterns heavy in ultra-processed foods, refined carbohydrates, and low in fiber leave these bacteria without substrate and short-circuit the whole system.

This is also why a one-size-fits-all fiber recommendation has limits. People's microbiome compositions differ enough that the same amount of the same fiber can yield quite different butyrate outputs. Fermented foods such as kimchi, sauerkraut, and kefir can help expand the diversity of fermentative bacteria, which is one reason they appear beneficial in the trial literature. But the foundation is fiber quantity and diversity, not fermented foods alone.

Sodium Butyrate Supplements

Direct butyrate supplementation, most commonly as sodium butyrate or a microencapsulated form designed to survive the upper digestive tract, is used in clinical research and is available as a consumer supplement. The trials discussed above used 600 mg of sodium butyrate per day, a dose that is representative of the research literature. Butyrate has a sharp, rancid odor, and the unpleasant smell led to development of microencapsulated forms that are more tolerable to take.

The available evidence suggests supplemental sodium butyrate can meaningfully lower inflammatory markers in people with active gut inflammation, but the case for using it in healthy adults is less clear. Unlike the fiber-based approach, which simultaneously improves microbiome diversity and provides other nutritional benefits, a sodium butyrate capsule is a more targeted intervention with a narrower evidence base. For most people without a diagnosed gut condition, improving fiber intake is likely to be both more effective and more broadly beneficial, because it shifts the whole microbiome rather than bypassing it.

That said, supplemental butyrate may be worth discussing with a healthcare provider if you have a condition associated with low butyrate such as inflammatory bowel disease, if you cannot tolerate high-fiber foods, or if your microbiome has been disrupted by repeated antibiotic courses. These scenarios represent situations where the microbiome itself may not reliably produce butyrate even with adequate fiber, and where direct supplementation may bridge a gap while the gut environment is being rebuilt.

Practical Steps for Supporting Butyrate Production

The most evidence-backed approach to raising butyrate levels is a dietary pattern that consistently delivers high amounts and variety of fermentable fiber. Aiming for 25 to 38 grams of total fiber per day, with a meaningful portion coming from sources high in inulin, resistant starch, and pectin, creates the conditions for robust butyrate production. Practical high-fiber foods that are well documented as butyrate precursors include cooked and cooled potatoes and rice (resistant starch increases with cooling), lentils and other legumes, garlic, onions, leeks, asparagus, Jerusalem artichoke, oats, ripe and unripe bananas, and apples. This is not an exotic or expensive list; it broadly describes a Mediterranean-style or whole-food dietary pattern.

Going from a low-fiber diet to a high-fiber one quickly can cause temporary bloating and gas as butyrate-producing bacteria expand and adapt. A gradual increase over two to four weeks reduces these side effects. Staying well hydrated also helps the digestive system handle the increased fiber load comfortably.

Tracking CRP over time is one of the most practical ways to evaluate whether your dietary and lifestyle choices are reducing inflammation. Because CRP reflects the cumulative output of many inputs, from gut health and diet to sleep and stress, measuring it before and after dietary changes gives you a concrete signal about whether things are moving in the right direction. Butyrate-supporting dietary changes typically take several weeks to shift the microbiome meaningfully, so comparing CRP levels after six to eight weeks of consistent higher-fiber eating tells you far more than a snapshot at any single point. CRP is a general wellness marker, not a diagnostic tool, and persistent elevation is always worth discussing with a healthcare provider who can put the number in the context of your full health picture.

Sources

• Firoozi D, Masoumi SJ, Mohammad-Kazem Hosseini Asl S, et al. Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial. Lipids in Health and Disease, 2024. pubmed.ncbi.nlm.nih.gov/39003477
• Roshanravan N, Alamdari NM, Jafarabadi MA, et al. Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Cytokine, 2020. pubmed.ncbi.nlm.nih.gov/32315958
• Xie Y, Zheng Y, Jiang F, Cai X. Meta-analytical insight on probiotic metabolites and inflammatory markers in diabetes. Frontiers in Cellular and Infection Microbiology, 2025. pubmed.ncbi.nlm.nih.gov/41059033
• Vijay A, Simpson L, Tooley M, et al. The anti-inflammatory effects of three different dietary supplement interventions. Journal of Translational Medicine, 2025. pubmed.ncbi.nlm.nih.gov/41094562

Frequently Asked Questions

Does butyrate reduce inflammation?

Yes. Butyrate, the short-chain fatty acid produced by gut bacteria fermenting dietary fiber, reduces inflammation through several mechanisms including inhibition of the NF-kB signaling pathway, suppression of NLRP3 inflammasome activation, and reinforcement of the intestinal barrier that prevents inflammatory bacterial fragments from entering the bloodstream. Randomized controlled trials have shown that sodium butyrate supplementation significantly lowers CRP and other inflammatory markers compared with placebo.

What foods increase butyrate production?

Butyrate is made by gut bacteria when they ferment dietary fiber, so foods that support butyrate production are those rich in fermentable fiber. The best sources include cooked and cooled potatoes and rice (which contain resistant starch that forms when cooked starches cool), lentils and other legumes, garlic, onions, leeks, asparagus, oats, and unripe bananas. A diverse, high-fiber diet is the most effective way to sustain butyrate production over time.

Should I take a sodium butyrate supplement?

For most people, improving dietary fiber intake is a more effective and broadly beneficial approach to raising butyrate than taking a supplement, because fiber reshapes the entire microbiome rather than bypassing it. Sodium butyrate supplements may be worth discussing with a healthcare provider if you have a gut condition such as inflammatory bowel disease, if you cannot tolerate high-fiber foods, or if your microbiome has been disrupted by repeated antibiotic use. Supplement doses used in clinical trials are typically around 600 mg per day.

How does butyrate affect CRP specifically?

Butyrate lowers CRP indirectly by reducing the upstream inflammatory signals that drive its production in the liver. Specifically, butyrate suppresses cytokines like IL-6 and IL-1B that signal the liver to produce CRP. A 2025 meta-analysis of 46 randomized trials found that higher butyrate levels were among the strongest predictors of CRP reduction, and a 2024 randomized trial in ulcerative colitis patients showed sodium butyrate supplementation significantly reduced hs-CRP compared with placebo over 12 weeks.